The effect of molnupiravir on post-acute outcome of COVID-19 survivors

J Infect. 2023 Oct;87(4):339-343. doi: 10.1016/j.jinf.2023.03.016. Epub 2023 Mar 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • Cytidine
  • Humans
  • Hydroxylamines

Substances

  • molnupiravir
  • Hydroxylamines
  • Cytidine
  • Antiviral Agents